pharma reports - Robuta Search

https://www.ophthalmologymanagement.com/news/2025/cloudbreak-pharma-reports-positive-phase-2-results-for-cbt004-in-patients-with-vascularized-pinguecula/ Cloudbreak Pharma Reports Positive Phase 2 Results for CBT004 in Patients With Vascularized... Jul 22, 2025 - Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through... pharma reports in patients cloudbreak positive phase https://www.optimumcomms.com/verona-pharma-reports-third-quarter-2021-financial-results-and-provides-corporate-update/ Verona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update - Optimum... Nov 9, 2021 - Enrollment in ENHANCE-1 48-week subset and ENHANCE-2 expected to complete around year-end 2021 ENHANCE Phase 3 program on track to report top-line data in 2022... pharma reports third quarter financial results corporate update verona https://eurobroadcastnews.com/article/855043056-bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | Euro Broadcast... Euro Broadcast News is an online news publication focusing on the Europe: Following the news from Europe pharma reports bridgebio grants nasdaq listing https://www.newswire.ca/news-releases/gc-pharma-reports-q1-2020-results-883869905.html GC Pharma Reports Q1 2020 Results /CNW/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited... pharma reports gc results https://health.economictimes.indiatimes.com/news/pharma/sun-pharma-reports-information-security-incident-isolates-impacted-it-assets/98360992 Sun Pharma reports "information security incident"; isolates impacted IT assets, ETHealthworld Sun Pharma: "The company is investigating the matter and appropriate containment and remediation actions are being taken in a controlled manner to address the... sun pharma information security reports incident isolates https://www.biopharmaapac.com/news/75/5846/-ascletis-pharma-reports-promising-results-for-asc30-oral-tablet-in-obesity-treatment.html Ascletis Pharma Reports Promising Results for ASC30 Oral Tablet in Obesity Treatment Ascletis Pharma Reports Promising Results for ASC30 Oral Tablet in Obesity Treatment pharma reports obesity treatment promising results oral https://www.pharma-reports.com/ Pharma Reports | Data Insights & Market Analytics Access real-time pharmaceutical market analytics, performance insights, and data reports through Pharma Reports by Base44. pharma reports data insights market analytics https://news.newswriter.ai/curated-news/202508/156951-lantern-pharma-reports-q2-2025-results-with-significant-advances-in-oncology-and-ai Lantern Pharma Reports Q2 2025 Results with Significant Advances in Oncology and AI | NewsWriter lantern pharma reports results significant advances https://igmpi.ac.in/news/clinical-research/ionis-pharma-reports-positive-results-from-the-phase-2-study-of-ion224-demonstrating-clinical-efficacy-in-treating-nashmash Ionis Pharma reports positive results from the phase 2 study of ION224, demonstrating clinical... pharma reports positive results from the phase study https://www.newsworthy.ai/curated/lantern-pharma-reports-strong-q3-2025-results-with-ai-driven-onc/202524081 Lantern Pharma Reports Strong Q3 2025 Results with AI-Driven Oncology Pipeline Progress |... Lantern Pharma announced positive Phase 1a trial results for LP-184 showing 48% clinical benefit rate and outlined expansion plans for multiple cancer... lantern pharma reports strong results ai https://www.prnewswire.com/news-releases/al-s-pharma-reports-positive-results-from-phase-2-study-of-ap-101-for-the-treatment-of-als-supporting-plans-for-a-confirmatory-phase-3-study-302634133.html AL-S Pharma Reports Positive Results from Phase 2 Study of AP-101 for the Treatment of ALS,... /PRNewswire/ -- AL-S Pharma, a clinical-stage biotech company dedicated to the development of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS)... pharma reports positive results for the al phase https://pharma.researchfloor.org/ Acta Pharma Reports | Journal | pharma reports acta journal https://markets.businessinsider.com/news/stocks/okyo-pharma-reports-new-phase-2-data-demonstrating-meaningful-improvements-in-patient-reported-quality-of-life-outcomes-with-urcosimod-in-neuropathic-corneal-pain-1035940883 OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported... LONDON and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developin... pharma reports new phase data demonstrating meaningful https://www.prnewswire.co.uk/news-releases/innocan-pharma-reports-first-quarter-2024-results-with-revenue-growth-of-over-4x-to-6-8-million-302156220.html Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6.8 Million /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on... pharma reports first quarter revenue growth results million https://www.biospace.com/cipher-pharma-reports-financial-and-operational-results-for-q1-2015-654105 Cipher Pharma Reports Financial And Operational Results For Q1 2015 - BioSpace pharma reports cipher financial operational results https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2045207&key=Accordion+Pill News for Medical Sales Reps: Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion... for medical sales reps pharma reports top line trial results https://news.trinzik.ai/frontier-tech-news/202604/421840-lantern-pharma-reports-2025-operational-progress-with-ai-driven-oncology-pipeline-and-15-billion-market-opportunity Lantern Pharma Reports 2025 Operational Progress with AI-Driven Oncology Pipeline and $15 Billion... lantern pharma reports operational progress ai https://www.europeancurrent.com/article/855043056-bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | The European... The European Current is an online news publication focusing on the Europe: Your daily news update on Europe pharma reports the european bridgebio grants nasdaq https://www.pharmaindustrial-india.com/news/gland-pharma-reports-revenue-of-inr-14058-million-in-q2fy25 Gland Pharma Reports Revenue of INR 14,058 Million in Q2FY25 - Global Pharma Gland Pharma Reports Revenue of INR 14,058 Million in Q2FY25 - Global Pharma pharma reports gland revenue inr million https://advos.io/en/lantern-pharma-reports-progress-in-ai-driven-oncology-pipeline-w/202630339 Lantern Pharma Reports Progress in AI-Driven Oncology Pipeline with Multiple 2026 Milestones | Advos lantern pharma reports progress ai driven https://www.lisavienna.at/news/detail/hookipa-pharma-reports-third-quarter-2019-financial-results-and-provides-a-corporate-update/ HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update -... Vienna, 12.11.2019: HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update - HOOKIPA Pharma Inc. (NASDAQ: HOOK,... pharma reports third quarter financial results corporate update provides https://aijourn.com/allos-pharma-acquires-global-rights-to-arbaclofen-reports-positive-asd-trial-results-and-grant-award/ Allos Pharma Acquires Global Rights to Arbaclofen, Reports Positive ASD Trial Results and Grant... Aug 21, 2025 - CAMBRIDGE, Mass., Aug. 21, 2025 /PRNewswire/ -- Allos Pharma Inc., announces key milestones advancing its mission to deliver effective treatments for Autism trial results allos pharma global rights https://www.pharmamanufacturing.com/production/aseptic-processing/product/11352420/jain-pharmabiotech-pharmaceutical-reports-jain-pharmabiotech-pharmaceutical-manufacturing Pharmaceutical Reports | Jain PharmaBiotech | Pharmaceutical Manufacturing | Pharma Manufacturing Report Analyzes Antiviral Therapeutics Market manufacturing pharma pharmaceutical reports jain https://money.rediff.com/companies/Orchid-Pharma-Ltd/12540151/share-holding Orchid Pharma Ltd. Share Holding - Ratios | Reports | Rediff Money Orchid Pharma Ltd. - the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts, expert advice, and... orchid pharma ltd share holding https://www.panabee.com/quotes/EVOK Evoke Pharma Quotes from Earnings Reports, Press Releases, and Transcripts | EVOK Find revealing Evoke Pharma quotes from press releases, transcripts, earnings reports, and other stock events. earnings reports press releases evoke pharma quotes